Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Fortinet, Inc.FTNT · Entity 2890 | Director | September 30, 2026 | October 02, 2026 |
| Fulgent Genetics, Inc.FLGT · Entity 2545 | Director · Chief Executive Officer · 10% owner | September 01, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Fortinet, Inc.
Report date September 30, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,056 |
Reported balance
After 2026-09-30 transaction · row 1
1 source rowRow 1 · 2026-09-30 · Exercise / conversion · Acquired 459 · Balance 10,056 F1: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 12, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 1,377 |
Reported balance
After 2026-09-30 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-09-30 · Exercise / conversion · Disposed 459 · Balance 1,377 F6: Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. F1: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 12, 2026. F7: The RSUs will vest in substantially equal increments on each of September 30, 2026, December 31, 2026, March 31, 2027, and the earlier of (i) June 30, 2027 and (ii) the date immediately preceding the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's Common Stock will be delivered to the Reporting Person following vesting. F8: RSUs do not expire; they either vest or are canceled prior to vest date. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 53,082 |
Reported balance
Holding disclosure · report date 2026-09-30 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 53,082 F2: Securities held by The Ming Hsieh Trust (the "Hsieh Trust"). Mr. Hsieh is the trustee of the Hsieh Trust and possesses the sole voting and dispositive power with respect to securities held by the Hsieh Trust. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 25 |
Reported balance
Holding disclosure · report date 2026-09-30 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 25 F3: These securities are held by the Pauline Hsieh Irrevocable Trust dated 05/12/04, of which the Reporting Person is a trustee. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 25 |
Reported balance
Holding disclosure · report date 2026-09-30 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 25 F4: These securities are held by the Tiffany Hsieh Irrevocable Trust dated 05/12/04, of which the Reporting Person is a trustee. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 143 |
Reported balance
Holding disclosure · report date 2026-09-30 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 143 F5: These securities are held by the Ming Hsieh Revocable Family Trust, of which the Reporting Person is a trustee. |
Filing footnotes · ownership attribution and instrument terms
F1: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 12, 2026.
F2: Securities held by The Ming Hsieh Trust (the "Hsieh Trust"). Mr. Hsieh is the trustee of the Hsieh Trust and possesses the sole voting and dispositive power with respect to securities held by the Hsieh Trust.
F3: These securities are held by the Pauline Hsieh Irrevocable Trust dated 05/12/04, of which the Reporting Person is a trustee.
F4: These securities are held by the Tiffany Hsieh Irrevocable Trust dated 05/12/04, of which the Reporting Person is a trustee.
F5: These securities are held by the Ming Hsieh Revocable Family Trust, of which the Reporting Person is a trustee.
F6: Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement.
F7: The RSUs will vest in substantially equal increments on each of September 30, 2026, December 31, 2026, March 31, 2027, and the earlier of (i) June 30, 2027 and (ii) the date immediately preceding the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's Common Stock will be delivered to the Reporting Person following vesting.
F8: RSUs do not expire; they either vest or are canceled prior to vest date.
Fulgent Genetics, Inc.
Report date September 01, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 885,952 |
Reported balance
After 2026-09-01 transaction · row 1
1 source rowRow 1 · 2026-09-01 · Tax withholding · Disposed 4,392 · Balance 885,952 F1: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 25, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2025. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 7,895,115 |
Reported balance
Holding disclosure · report date 2026-09-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 7,895,115 F2: Securities held by The Ming Hsieh Trust (the "Hsieh Trust"). Mr. Hsieh is the trustee of the Hsieh Trust and possesses the sole voting and dispositive power with respect to securities held by the Hsieh Trust. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 220,816 |
Reported balance
Holding disclosure · report date 2026-09-01 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 220,816 F3: Securities held by the Dynasty Trust. Mr. Hsieh is the grantor of the Dynasty Trust and he and his spouse, Eva Hsieh, and Jian Xie serve on the investment committee of the Dynasty Trust. Mr. Hsieh disclaims any beneficial interest except with respect to any pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectUniform Transfer to Minor Account | 1,000 |
Reported balance
Holding disclosure · report date 2026-09-01 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 1,000 F4: Shares held in a Uniform Transfers to Minor Act account for which Ming Hsieh acts as custodian and possesses the sole voting and dispositive power. |
| Common StockSEC Table I · non-derivative | IndirectBy Immediate Family | 1,000 |
Reported balance
Holding disclosure · report date 2026-09-01 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 1,000 F5: Shares, which were previously held in a Uniform Transfers to Minor Act account, now held by an immediate family member residing in the same household as Ming Hsieh. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 25, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2025.
F2: Securities held by The Ming Hsieh Trust (the "Hsieh Trust"). Mr. Hsieh is the trustee of the Hsieh Trust and possesses the sole voting and dispositive power with respect to securities held by the Hsieh Trust.
F3: Securities held by the Dynasty Trust. Mr. Hsieh is the grantor of the Dynasty Trust and he and his spouse, Eva Hsieh, and Jian Xie serve on the investment committee of the Dynasty Trust. Mr. Hsieh disclaims any beneficial interest except with respect to any pecuniary interest therein.
F4: Shares held in a Uniform Transfers to Minor Act account for which Ming Hsieh acts as custodian and possesses the sole voting and dispositive power.
F5: Shares, which were previously held in a Uniform Transfers to Minor Act account, now held by an immediate family member residing in the same household as Ming Hsieh.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 2, 2026 03:44 UTC | Fortinet, Inc. FTNT · Entity 2890 | Exercise / conversionRestricted Stock Units · Derivative | 459 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001302110-26-000034 · form4-10012026_111025.xml · derivative · entry 6 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,377 Underlying: Common Stock · 459 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 12, 2026. F7 · derivative.exercise_date: The RSUs will vest in substantially equal increments on each of September 30, 2026, December 31, 2026, March 31, 2027, and the earlier of (i) June 30, 2027 and (ii) the date immediately preceding the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's Common Stock will be delivered to the Reporting Person following vesting. F8 · derivative.expiration_date: RSUs do not expire; they either vest or are canceled prior to vest date. Read SEC document |
| September 30, 2026 Filed Oct 2, 2026 03:44 UTC | Fortinet, Inc. FTNT · Entity 2890 | Exercise / conversionCommon Stock | 459 | $0.00 | $0.00 |
DisclosureSEC source: 0001302110-26-000034 · form4-10012026_111025.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,056 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 12, 2026. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 23:47 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Tax withholdingCommon Stock | 4,392 | $19.59 | $86,039.28 |
DisclosureSEC source: 0001302110-26-000032 · ownership.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 885,952 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 25, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2025. Read SEC document |
| August 26, 2026 Filed Aug 28, 2026 22:06 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Tax withholdingCommon Stock | 2,949 | $19.81 | $58,419.69 |
DisclosureSEC source: 0001302110-26-000030 · ownership.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 890,344 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024. Read SEC document |
| August 12, 2026 Filed Aug 13, 2026 21:08 UTC | Fortinet, Inc. FTNT · Entity 2890 | GrantRestricted Stock Units · Derivative | 1,836 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001302110-26-000028 · form4-08132026_090831.xml · derivative · entry 1 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,836 Underlying: Common Stock · 1,836 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon settlement. F2 · derivative.exercise_date: The RSUs will vest in substantially equal increments on each of September 30, 2026, December 31, 2026, March 31, 2027, and the earlier of (i) June 30, 2027 and (ii) the date immediately preceding the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's Common Stock will be delivered to the Reporting Person following vesting. F3 · derivative.expiration_date: RSUs do not expire; they either vest or are canceled prior to vest date Read SEC document |
| June 11, 2026 Filed Jun 12, 2026 21:42 UTC | Fortinet, Inc. FTNT · Entity 2890 | Exercise / conversionRestricted Stock Units · Derivative | 650 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001302110-26-000024 · form4-06122026_090640.xml · derivative · entry 6 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 650 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 20, 2025. F7 · derivative.exercise_date: The RSUs will vest in substantially equal increments on each of September 30, 2025, December 31, 2025, March 31, 2026, and the earlier of (i) June 30, 2026 and (ii) the date immediately preceding the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's Common Stock will be delivered to the Reporting Person following vesting. F8 · derivative.expiration_date: RSUs do not expire; they either vest or are canceled prior to vest date Read SEC document |
| June 11, 2026 Filed Jun 12, 2026 21:42 UTC | Fortinet, Inc. FTNT · Entity 2890 | Exercise / conversionCommon Stock | 650 | $0.00 | $0.00 |
DisclosureSEC source: 0001302110-26-000024 · form4-06122026_090640.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,597 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 20, 2025. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 21:29 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Tax withholdingCommon Stock | 4,392 | $18.09 | $79,451.28 |
DisclosureSEC source: 0001302110-26-000022 · ownership.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 893,293 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 25, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2025. Read SEC document |
| May 26, 2026 Filed May 27, 2026 23:42 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Tax withholdingCommon Stock | 2,949 | $17.67 | $52,108.83 |
DisclosureSEC source: 0001302110-26-000019 · ownership.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 897,685 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024. Read SEC document |
| March 31, 2026 Filed Apr 1, 2026 22:40 UTC | Fortinet, Inc. FTNT · Entity 2890 | Exercise / conversionRestricted Stock Units · Derivative | 649 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001302110-26-000016 · form4-04012026_100439.xml · derivative · entry 5 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 650 Underlying: Common Stock · 649 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 20, 2025. F6 · derivative.exercise_date: The RSUs will vest in substantially equal increments on each of September 30, 2025, December 31, 2025, March 31, 2026, and the earlier of (i) June 30, 2026 and (ii) the date immediately preceding the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's Common Stock will be delivered to the Reporting Person following vesting. F7 · derivative.expiration_date: RSUs do not expire; they either vest or are canceled prior to vest date Read SEC document |
| March 31, 2026 Filed Apr 1, 2026 22:40 UTC | Fortinet, Inc. FTNT · Entity 2890 | Exercise / conversionCommon Stock | 649 | $0.00 | $0.00 |
DisclosureSEC source: 0001302110-26-000016 · form4-04012026_100439.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,952 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 20, 2025. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 21:24 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | OtherForward sale contract (obligation to sell) · Derivative | 750,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001302110-26-000007 · ownership.xml · derivative · entry 6 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 0 Underlying: Common Stock · 750,000 shares Expires not disclosed F5 · derivative.exercise_price: Previously, on August 21, 2023, the Hsieh Trust entered into a prepaid variable forward agreement (the "2023 Agreement") with an unaffiliated bank (the "Bank"). The 2023 Agreement obligated the Hsieh Trust to deliver up to 750,000 shares of the issuer's common stock, $0.0001 par value per share ("Common Stock") (or, at the Hsieh Trust's election, an equivalent amount of cash) to settle the 2023 Agreement. F6 · derivative.exercise_price: On March 9, 2026, the Hsieh Trust elected to cancel the 2023 Agreement with respect to all 750,000 shares. In connection with the cancellation, the Hsieh Trust paid an aggregate of $10,708,875 to the Bank. Following the payment and cancellation described above, the 750,000 shares held by the reporting person that were previously subject to the prepaid forward contract are no longer pledged to the Bank. F5 · kind: Previously, on August 21, 2023, the Hsieh Trust entered into a prepaid variable forward agreement (the "2023 Agreement") with an unaffiliated bank (the "Bank"). The 2023 Agreement obligated the Hsieh Trust to deliver up to 750,000 shares of the issuer's common stock, $0.0001 par value per share ("Common Stock") (or, at the Hsieh Trust's election, an equivalent amount of cash) to settle the 2023 Agreement. F6 · kind: On March 9, 2026, the Hsieh Trust elected to cancel the 2023 Agreement with respect to all 750,000 shares. In connection with the cancellation, the Hsieh Trust paid an aggregate of $10,708,875 to the Bank. Following the payment and cancellation described above, the 750,000 shares held by the reporting person that were previously subject to the prepaid forward contract are no longer pledged to the Bank. F5 · shares: Previously, on August 21, 2023, the Hsieh Trust entered into a prepaid variable forward agreement (the "2023 Agreement") with an unaffiliated bank (the "Bank"). The 2023 Agreement obligated the Hsieh Trust to deliver up to 750,000 shares of the issuer's common stock, $0.0001 par value per share ("Common Stock") (or, at the Hsieh Trust's election, an equivalent amount of cash) to settle the 2023 Agreement. F5 · price: Previously, on August 21, 2023, the Hsieh Trust entered into a prepaid variable forward agreement (the "2023 Agreement") with an unaffiliated bank (the "Bank"). The 2023 Agreement obligated the Hsieh Trust to deliver up to 750,000 shares of the issuer's common stock, $0.0001 par value per share ("Common Stock") (or, at the Hsieh Trust's election, an equivalent amount of cash) to settle the 2023 Agreement. F6 · price: On March 9, 2026, the Hsieh Trust elected to cancel the 2023 Agreement with respect to all 750,000 shares. In connection with the cancellation, the Hsieh Trust paid an aggregate of $10,708,875 to the Bank. Following the payment and cancellation described above, the 750,000 shares held by the reporting person that were previously subject to the prepaid forward contract are no longer pledged to the Bank. F5 · derivative.exercise_date: Previously, on August 21, 2023, the Hsieh Trust entered into a prepaid variable forward agreement (the "2023 Agreement") with an unaffiliated bank (the "Bank"). The 2023 Agreement obligated the Hsieh Trust to deliver up to 750,000 shares of the issuer's common stock, $0.0001 par value per share ("Common Stock") (or, at the Hsieh Trust's election, an equivalent amount of cash) to settle the 2023 Agreement. F6 · derivative.exercise_date: On March 9, 2026, the Hsieh Trust elected to cancel the 2023 Agreement with respect to all 750,000 shares. In connection with the cancellation, the Hsieh Trust paid an aggregate of $10,708,875 to the Bank. Following the payment and cancellation described above, the 750,000 shares held by the reporting person that were previously subject to the prepaid forward contract are no longer pledged to the Bank. F5 · derivative.expiration_date: Previously, on August 21, 2023, the Hsieh Trust entered into a prepaid variable forward agreement (the "2023 Agreement") with an unaffiliated bank (the "Bank"). The 2023 Agreement obligated the Hsieh Trust to deliver up to 750,000 shares of the issuer's common stock, $0.0001 par value per share ("Common Stock") (or, at the Hsieh Trust's election, an equivalent amount of cash) to settle the 2023 Agreement. F6 · derivative.expiration_date: On March 9, 2026, the Hsieh Trust elected to cancel the 2023 Agreement with respect to all 750,000 shares. In connection with the cancellation, the Hsieh Trust paid an aggregate of $10,708,875 to the Bank. Following the payment and cancellation described above, the 750,000 shares held by the reporting person that were previously subject to the prepaid forward contract are no longer pledged to the Bank. F1 · ownership.nature: Securities held by The Ming Hsieh Trust (the "Hsieh Trust"). Mr. Hsieh is the trustee of the Hsieh Trust and possesses the sole voting and dispositive power with respect to securities held by the Hsieh Trust. F5 · ownership.nature: Previously, on August 21, 2023, the Hsieh Trust entered into a prepaid variable forward agreement (the "2023 Agreement") with an unaffiliated bank (the "Bank"). The 2023 Agreement obligated the Hsieh Trust to deliver up to 750,000 shares of the issuer's common stock, $0.0001 par value per share ("Common Stock") (or, at the Hsieh Trust's election, an equivalent amount of cash) to settle the 2023 Agreement. F6 · ownership.nature: On March 9, 2026, the Hsieh Trust elected to cancel the 2023 Agreement with respect to all 750,000 shares. In connection with the cancellation, the Hsieh Trust paid an aggregate of $10,708,875 to the Bank. Following the payment and cancellation described above, the 750,000 shares held by the reporting person that were previously subject to the prepaid forward contract are no longer pledged to the Bank. Read SEC document |
| March 09, 2026 Filed Mar 31, 2026 20:57 UTC Amendment | Fulgent Genetics, Inc. FLGT · Entity 2545 | OtherForward sale contract (obligation to sell) · Derivative | 750,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001302110-26-000014 · ownership.xml · derivative · entry 6 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner Ming Hsieh Trust · CIK 0001836339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 0 Underlying: Common Stock · 750,000 shares Expires not disclosed F5 · derivative.exercise_price: Previously, on August 21, 2023, the Hsieh Trust entered into a prepaid variable forward agreement (the "2023 Agreement") with an unaffiliated bank (the "Bank"). The 2023 Agreement obligated the Hsieh Trust to deliver up to 750,000 shares of the issuer's common stock, $0.0001 par value per share ("Common Stock") (or, at the Hsieh Trust's election, an equivalent amount of cash) to settle the 2023 Agreement. F6 · derivative.exercise_price: On March 9, 2026, the Hsieh Trust elected to cancel the 2023 Agreement with respect to all 750,000 shares. In connection with the cancellation, the Hsieh Trust paid an aggregate of $10,708,875 to the Bank. Following the payment and cancellation described above, the 750,000 shares held by the reporting person that were previously subject to the prepaid forward contract are no longer pledged to the Bank. F5 · kind: Previously, on August 21, 2023, the Hsieh Trust entered into a prepaid variable forward agreement (the "2023 Agreement") with an unaffiliated bank (the "Bank"). The 2023 Agreement obligated the Hsieh Trust to deliver up to 750,000 shares of the issuer's common stock, $0.0001 par value per share ("Common Stock") (or, at the Hsieh Trust's election, an equivalent amount of cash) to settle the 2023 Agreement. F6 · kind: On March 9, 2026, the Hsieh Trust elected to cancel the 2023 Agreement with respect to all 750,000 shares. In connection with the cancellation, the Hsieh Trust paid an aggregate of $10,708,875 to the Bank. Following the payment and cancellation described above, the 750,000 shares held by the reporting person that were previously subject to the prepaid forward contract are no longer pledged to the Bank. F5 · shares: Previously, on August 21, 2023, the Hsieh Trust entered into a prepaid variable forward agreement (the "2023 Agreement") with an unaffiliated bank (the "Bank"). The 2023 Agreement obligated the Hsieh Trust to deliver up to 750,000 shares of the issuer's common stock, $0.0001 par value per share ("Common Stock") (or, at the Hsieh Trust's election, an equivalent amount of cash) to settle the 2023 Agreement. F5 · price: Previously, on August 21, 2023, the Hsieh Trust entered into a prepaid variable forward agreement (the "2023 Agreement") with an unaffiliated bank (the "Bank"). The 2023 Agreement obligated the Hsieh Trust to deliver up to 750,000 shares of the issuer's common stock, $0.0001 par value per share ("Common Stock") (or, at the Hsieh Trust's election, an equivalent amount of cash) to settle the 2023 Agreement. F6 · price: On March 9, 2026, the Hsieh Trust elected to cancel the 2023 Agreement with respect to all 750,000 shares. In connection with the cancellation, the Hsieh Trust paid an aggregate of $10,708,875 to the Bank. Following the payment and cancellation described above, the 750,000 shares held by the reporting person that were previously subject to the prepaid forward contract are no longer pledged to the Bank. F5 · derivative.exercise_date: Previously, on August 21, 2023, the Hsieh Trust entered into a prepaid variable forward agreement (the "2023 Agreement") with an unaffiliated bank (the "Bank"). The 2023 Agreement obligated the Hsieh Trust to deliver up to 750,000 shares of the issuer's common stock, $0.0001 par value per share ("Common Stock") (or, at the Hsieh Trust's election, an equivalent amount of cash) to settle the 2023 Agreement. F6 · derivative.exercise_date: On March 9, 2026, the Hsieh Trust elected to cancel the 2023 Agreement with respect to all 750,000 shares. In connection with the cancellation, the Hsieh Trust paid an aggregate of $10,708,875 to the Bank. Following the payment and cancellation described above, the 750,000 shares held by the reporting person that were previously subject to the prepaid forward contract are no longer pledged to the Bank. F5 · derivative.expiration_date: Previously, on August 21, 2023, the Hsieh Trust entered into a prepaid variable forward agreement (the "2023 Agreement") with an unaffiliated bank (the "Bank"). The 2023 Agreement obligated the Hsieh Trust to deliver up to 750,000 shares of the issuer's common stock, $0.0001 par value per share ("Common Stock") (or, at the Hsieh Trust's election, an equivalent amount of cash) to settle the 2023 Agreement. F6 · derivative.expiration_date: On March 9, 2026, the Hsieh Trust elected to cancel the 2023 Agreement with respect to all 750,000 shares. In connection with the cancellation, the Hsieh Trust paid an aggregate of $10,708,875 to the Bank. Following the payment and cancellation described above, the 750,000 shares held by the reporting person that were previously subject to the prepaid forward contract are no longer pledged to the Bank. F1 · ownership.nature: Securities held by The Ming Hsieh Trust (the "Hsieh Trust"). Mr. Hsieh is the trustee of the Hsieh Trust and possesses the sole voting and dispositive power with respect to securities held by the Hsieh Trust. F5 · ownership.nature: Previously, on August 21, 2023, the Hsieh Trust entered into a prepaid variable forward agreement (the "2023 Agreement") with an unaffiliated bank (the "Bank"). The 2023 Agreement obligated the Hsieh Trust to deliver up to 750,000 shares of the issuer's common stock, $0.0001 par value per share ("Common Stock") (or, at the Hsieh Trust's election, an equivalent amount of cash) to settle the 2023 Agreement. F6 · ownership.nature: On March 9, 2026, the Hsieh Trust elected to cancel the 2023 Agreement with respect to all 750,000 shares. In connection with the cancellation, the Hsieh Trust paid an aggregate of $10,708,875 to the Bank. Following the payment and cancellation described above, the 750,000 shares held by the reporting person that were previously subject to the prepaid forward contract are no longer pledged to the Bank. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 01:00 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Tax withholdingCommon Stock | 17,566 | $15.33 | $269,286.78 |
DisclosureSEC source: 0001302110-26-000005 · ownership.xml · nonDerivative · entry 2 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 900,634 F2 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 25, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2025. Read SEC document |
| February 26, 2026 Filed Mar 3, 2026 01:00 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Tax withholdingCommon Stock | 2,949 | $24.76 | $73,017.24 |
DisclosureSEC source: 0001302110-26-000005 · ownership.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 918,200 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 01:17 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GrantCommon Stock | 69,294 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-072637 · ownership.xml · nonDerivative · entry 8 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 921,149 F8 · shares: Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after March 1, 2026, and 1/12th of such shares vesting at the end of every three-month period thereafter over the remaining 24 months, subject to continued service for Issuer on each vesting date. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 01:17 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Tax withholdingCommon Stock | 31,760 | $23.09 | $733,338.40 |
DisclosureSEC source: 0001193125-26-072637 · ownership.xml · nonDerivative · entry 7 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 851,855 F7 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 25, 2025. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 01:17 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Tax withholdingCommon Stock | 21,354 | $23.09 | $493,063.86 |
DisclosureSEC source: 0001193125-26-072637 · ownership.xml · nonDerivative · entry 6 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 883,615 F6 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 26, 2024. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 01:17 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Tax withholdingCommon Stock | 10,230 | $23.09 | $236,210.70 |
DisclosureSEC source: 0001193125-26-072637 · ownership.xml · nonDerivative · entry 5 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 904,969 F5 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 23, 2023. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 01:17 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GrantCommon Stock | 59,276 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-072637 · ownership.xml · nonDerivative · entry 4 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 915,199 F4 · shares: Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 25, 2025. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 01:17 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GrantCommon Stock | 39,802 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-072637 · ownership.xml · nonDerivative · entry 3 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 855,923 F3 · shares: Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 26, 2024. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 01:17 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GrantCommon Stock | 19,067 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-072637 · ownership.xml · nonDerivative · entry 2 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 816,121 F2 · shares: Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 23, 2023. Read SEC document |
| February 23, 2026 Filed Feb 26, 2026 01:17 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Tax withholdingCommon Stock | 2,167 | $23.01 | $49,862.67 |
DisclosureSEC source: 0001193125-26-072637 · ownership.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 797,054 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023. Read SEC document |
| December 31, 2025 Filed Jan 1, 2026 01:05 UTC | Fortinet, Inc. FTNT · Entity 2890 | Exercise / conversionRestricted Stock Units · Derivative | 649 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001302110-25-000010 · form4-01012026_010146.xml · derivative · entry 2 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,299 Underlying: Common Stock · 649 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 20, 2025. F3 · derivative.exercise_date: The RSUs will vest in substantially equal increments on each of September 30, 2025, December 31, 2025, March 31, 2026, and the earlier of (i) June 30, 2026 and (ii) the date immediately preceding the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's Common Stock will be delivered to the Reporting Person following vesting. F4 · derivative.expiration_date: RSUs do not expire; they either vest or are canceled prior to vest date Read SEC document |
| December 31, 2025 Filed Jan 1, 2026 01:05 UTC | Fortinet, Inc. FTNT · Entity 2890 | Exercise / conversionCommon Stock | 649 | $0.00 | $0.00 |
DisclosureSEC source: 0001302110-25-000010 · form4-01012026_010146.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,385 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 20, 2025. Read SEC document |
| November 26, 2025 Filed Dec 2, 2025 00:00 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Tax withholdingCommon Stock | 2,944 | $30.15 | $88,761.60 |
DisclosureSEC source: 0001193125-25-304200 · ownership.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 799,221 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024. Read SEC document |
| November 23, 2025 Filed Nov 25, 2025 21:30 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Tax withholdingCommon Stock | 2,116 | $30.00 | $63,480.00 |
DisclosureSEC source: 0001193125-25-297327 · ownership.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 802,165 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:22 UTC | Fortinet, Inc. FTNT · Entity 2890 | Exercise / conversionRestricted Stock Units · Derivative | 649 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001302110-25-000008 · form4-10022025_081003.xml · derivative · entry 2 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,948 Underlying: Common Stock · 649 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 20, 2025. F3 · derivative.exercise_date: The RSUs will vest in substantially equal increments on each of September 30, 2025, December 31, 2025, March 31, 2026, and the earlier of (i) June 30, 2026 and (ii) the date immediately preceding the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's Common Stock will be delivered to the Reporting Person following vesting. F4 · derivative.expiration_date: RSUs do not expire; they either vest or are canceled prior to vest date Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:22 UTC | Fortinet, Inc. FTNT · Entity 2890 | Exercise / conversionCommon Stock | 649 | $0.00 | $0.00 |
DisclosureSEC source: 0001302110-25-000008 · form4-10022025_081003.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,736 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 20, 2025. Read SEC document |
| August 26, 2025 Filed Aug 28, 2025 22:55 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Tax withholdingCommon Stock | 2,944 | $21.47 | $63,207.68 |
DisclosureSEC source: 0001302110-25-000006 · ownership.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 804,281 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024. Read SEC document |
| August 23, 2025 Filed Aug 26, 2025 23:12 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Tax withholdingCommon Stock | 2,115 | $21.77 | $46,043.55 |
DisclosureSEC source: 0001302110-25-000004 · ownership.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 807,225 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023. Read SEC document |
| August 20, 2025 Filed Aug 22, 2025 21:20 UTC | Fortinet, Inc. FTNT · Entity 2890 | GrantRestricted Stock Units · Derivative | 2,597 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-022787 · form4-08222025_090834.xml · derivative · entry 1 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,597 Underlying: Common Stock · 2,597 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon settlement. F2 · derivative.exercise_date: The RSUs will vest in substantially equal increments on each of September 30, 2025, December 31, 2025, March 31, 2026, and the earlier of (i) June 30, 2026 and (ii) the date immediately preceding the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's Common Stock will be delivered to the Reporting Person following vesting. F3 · derivative.expiration_date: RSUs do not expire; they either vest or are canceled prior to vest date Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 20:56 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Tax withholdingCommon Stock | 1,339 | $18.53 | $24,811.67 |
DisclosureSEC source: 0000950170-25-103191 · ownership.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 809,340 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 1, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on August 3, 2022. Read SEC document |
| June 12, 2025 Filed Jun 13, 2025 20:37 UTC | Fortinet, Inc. FTNT · Entity 2890 | Exercise / conversionRestricted Stock Units · Derivative | 1,130 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-017211 · form4-06132025_080608.xml · derivative · entry 2 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,130 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 20, 2024. F3 · derivative.exercise_date: The RSUs will vest in substantially equal increments on each of September 30, 2024, December 31, 2024, March 31, 2025, and the earlier of (i) June 30, 2025 and (ii) the date immediately preceding the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's Common Stock will be delivered to the Reporting Person following vesting. F4 · derivative.expiration_date: RSUs do not expire; they either vest or are canceled prior to vest date. Read SEC document |
| June 12, 2025 Filed Jun 13, 2025 20:37 UTC | Fortinet, Inc. FTNT · Entity 2890 | Exercise / conversionCommon Stock | 1,130 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-017211 · form4-06132025_080608.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,087 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 20, 2024. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 20:30 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | OtherForward sale contract (obligation to sell) · Derivative | 800,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-084869 · ownership.xml · derivative · entry 6 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner Ming Hsieh Trust · CIK 0001836339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 0 Underlying: Common Stock · 800,000 shares Expires not disclosed F4 · derivative.exercise_price: Previously, on September 14, 2022, the Trust entered into a prepaid variable forward agreement (the "2022 Agreement") with an unaffiliated bank (the "Bank"). The 2022 Agreement obligated the Trust to deliver up to 800,000 shares of the issuer's common stock, $0.0001 par value per share ("Common Stock") (or, at the Trust's election, an equivalent amount of cash) to settle the 2022 Agreement. F5 · derivative.exercise_price: On June 9, 2025, the Trust elected to cancel the 2022 Agreement with respect to all 800,000 shares. In connection with the cancellation, the Trust paid an aggregate of $16,446,960.00 to the Bank. Following the payment and cancellation described above, the 800,000 shares held by the reporting person that were previously subject to the prepaid forward contract are no longer pledged to the Bank. F4 · kind: Previously, on September 14, 2022, the Trust entered into a prepaid variable forward agreement (the "2022 Agreement") with an unaffiliated bank (the "Bank"). The 2022 Agreement obligated the Trust to deliver up to 800,000 shares of the issuer's common stock, $0.0001 par value per share ("Common Stock") (or, at the Trust's election, an equivalent amount of cash) to settle the 2022 Agreement. F5 · kind: On June 9, 2025, the Trust elected to cancel the 2022 Agreement with respect to all 800,000 shares. In connection with the cancellation, the Trust paid an aggregate of $16,446,960.00 to the Bank. Following the payment and cancellation described above, the 800,000 shares held by the reporting person that were previously subject to the prepaid forward contract are no longer pledged to the Bank. F4 · shares: Previously, on September 14, 2022, the Trust entered into a prepaid variable forward agreement (the "2022 Agreement") with an unaffiliated bank (the "Bank"). The 2022 Agreement obligated the Trust to deliver up to 800,000 shares of the issuer's common stock, $0.0001 par value per share ("Common Stock") (or, at the Trust's election, an equivalent amount of cash) to settle the 2022 Agreement. F4 · price: Previously, on September 14, 2022, the Trust entered into a prepaid variable forward agreement (the "2022 Agreement") with an unaffiliated bank (the "Bank"). The 2022 Agreement obligated the Trust to deliver up to 800,000 shares of the issuer's common stock, $0.0001 par value per share ("Common Stock") (or, at the Trust's election, an equivalent amount of cash) to settle the 2022 Agreement. F5 · price: On June 9, 2025, the Trust elected to cancel the 2022 Agreement with respect to all 800,000 shares. In connection with the cancellation, the Trust paid an aggregate of $16,446,960.00 to the Bank. Following the payment and cancellation described above, the 800,000 shares held by the reporting person that were previously subject to the prepaid forward contract are no longer pledged to the Bank. F4 · derivative.exercise_date: Previously, on September 14, 2022, the Trust entered into a prepaid variable forward agreement (the "2022 Agreement") with an unaffiliated bank (the "Bank"). The 2022 Agreement obligated the Trust to deliver up to 800,000 shares of the issuer's common stock, $0.0001 par value per share ("Common Stock") (or, at the Trust's election, an equivalent amount of cash) to settle the 2022 Agreement. F5 · derivative.exercise_date: On June 9, 2025, the Trust elected to cancel the 2022 Agreement with respect to all 800,000 shares. In connection with the cancellation, the Trust paid an aggregate of $16,446,960.00 to the Bank. Following the payment and cancellation described above, the 800,000 shares held by the reporting person that were previously subject to the prepaid forward contract are no longer pledged to the Bank. F4 · derivative.expiration_date: Previously, on September 14, 2022, the Trust entered into a prepaid variable forward agreement (the "2022 Agreement") with an unaffiliated bank (the "Bank"). The 2022 Agreement obligated the Trust to deliver up to 800,000 shares of the issuer's common stock, $0.0001 par value per share ("Common Stock") (or, at the Trust's election, an equivalent amount of cash) to settle the 2022 Agreement. F5 · derivative.expiration_date: On June 9, 2025, the Trust elected to cancel the 2022 Agreement with respect to all 800,000 shares. In connection with the cancellation, the Trust paid an aggregate of $16,446,960.00 to the Bank. Following the payment and cancellation described above, the 800,000 shares held by the reporting person that were previously subject to the prepaid forward contract are no longer pledged to the Bank. F1 · ownership.nature: Securities held by The Ming Hsieh Trust (the "Trust"). Mr. Hsieh is the trustee of the Trust and possesses the sole voting and dispositive power with respect to securities held by the Trust. F4 · ownership.nature: Previously, on September 14, 2022, the Trust entered into a prepaid variable forward agreement (the "2022 Agreement") with an unaffiliated bank (the "Bank"). The 2022 Agreement obligated the Trust to deliver up to 800,000 shares of the issuer's common stock, $0.0001 par value per share ("Common Stock") (or, at the Trust's election, an equivalent amount of cash) to settle the 2022 Agreement. F5 · ownership.nature: On June 9, 2025, the Trust elected to cancel the 2022 Agreement with respect to all 800,000 shares. In connection with the cancellation, the Trust paid an aggregate of $16,446,960.00 to the Bank. Following the payment and cancellation described above, the 800,000 shares held by the reporting person that were previously subject to the prepaid forward contract are no longer pledged to the Bank. Read SEC document |
| May 26, 2025 Filed May 28, 2025 20:16 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Tax withholdingCommon Stock | 2,944 | $20.31 | $59,792.64 |
DisclosureSEC source: 0000950170-25-078347 · ownership.xml · nonDerivative · entry 2 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 810,679 F2 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024. Read SEC document |
| May 23, 2025 Filed May 28, 2025 20:16 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Tax withholdingCommon Stock | 2,116 | $20.31 | $42,975.96 |
DisclosureSEC source: 0000950170-25-078347 · ownership.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 813,623 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023. Read SEC document |
| May 01, 2025 Filed May 5, 2025 20:51 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Tax withholdingCommon Stock | 1,339 | $17.25 | $23,097.75 |
DisclosureSEC source: 0000950170-25-063643 · ownership.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 815,739 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 1, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on August 3, 2022. Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 20:08 UTC | Fortinet, Inc. FTNT · Entity 2890 | Exercise / conversionRestricted Stock Units · Derivative | 1,130 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-009353 · form4-04012025_080412.xml · derivative · entry 2 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,130 Underlying: Common Stock · 1,130 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 20, 2024. F3 · derivative.exercise_date: The RSUs will vest in substantially equal increments on each of September 30, 2024, December 31, 2024, March 31, 2025, and the earlier of (i) June 30, 2025 and (ii) the date immediately preceding the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's Common Stock will be delivered to the Reporting Person following vesting. F4 · derivative.expiration_date: RSUs do not expire; they either vest or are canceled prior to vest date. Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 20:08 UTC | Fortinet, Inc. FTNT · Entity 2890 | Exercise / conversionCommon Stock | 1,130 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-009353 · form4-04012025_080412.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,957 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 20, 2024. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 02:03 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Tax withholdingCommon Stock | 11,773 | $16.24 | $191,193.52 |
DisclosureSEC source: 0000950170-25-029433 · ownership.xml · nonDerivative · entry 8 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 817,078 F8 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024. Read SEC document |
| February 25, 2025 Filed Feb 28, 2025 02:03 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GrantCommon Stock | 98,220 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-029433 · ownership.xml · nonDerivative · entry 7 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 828,851 F7 · shares: Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after March 1, 2025, and 1/12th of such shares vesting at the end of every three-month period thereafter over the remaining 24 months, subject to continued service for Issuer on each vesting date. Read SEC document |
| February 25, 2025 Filed Feb 28, 2025 02:03 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Tax withholdingCommon Stock | 19,997 | $16.29 | $325,751.13 |
DisclosureSEC source: 0000950170-25-029433 · ownership.xml · nonDerivative · entry 6 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 730,631 F6 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 26, 2024. Read SEC document |
| February 25, 2025 Filed Feb 28, 2025 02:03 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Tax withholdingCommon Stock | 9,543 | $16.29 | $155,455.47 |
DisclosureSEC source: 0000950170-25-029433 · ownership.xml · nonDerivative · entry 5 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 750,628 F5 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 23, 2023. Read SEC document |
| February 25, 2025 Filed Feb 28, 2025 02:03 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Tax withholdingCommon Stock | 6,041 | $16.29 | $98,407.89 |
DisclosureSEC source: 0000950170-25-029433 · ownership.xml · nonDerivative · entry 4 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 760,171 F4 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 28, 2022. Read SEC document |
| February 25, 2025 Filed Feb 28, 2025 02:03 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GrantCommon Stock | 37,197 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-029433 · ownership.xml · nonDerivative · entry 3 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 766,212 F3 · shares: Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 26, 2024. Read SEC document |
| February 25, 2025 Filed Feb 28, 2025 02:03 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GrantCommon Stock | 17,820 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-029433 · ownership.xml · nonDerivative · entry 2 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 729,015 F2 · shares: Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 23, 2023. Read SEC document |
| February 25, 2025 Filed Feb 28, 2025 02:03 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GrantCommon Stock | 11,280 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-029433 · ownership.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 711,195 F1 · shares: Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 28, 2022. Read SEC document |
| February 23, 2025 Filed Feb 25, 2025 22:26 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Tax withholdingCommon Stock | 2,324 | $16.46 | $38,253.04 |
DisclosureSEC source: 0000950170-25-026886 · ownership.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 699,915 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.